Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 93,106 | 52,755 | 68,661 | 90,372 | 83,808 |
| Cost of Goods | 13,340 | 18,180 | 24,359 | 43,321 | 21,105 |
| Gross Profit | 79,766 | 34,575 | 44,302 | 47,051 | 62,703 |
| Operating Expenses | 78,511 | 41,764 | 64,236 | 240,650 | 81,155 |
| Operating Income | 1,595 | -7,009 | -19,575 | -193,278 | -18,347 |
| Interest Expense | 6,798 | 6,700 | 6,604 | 6,510 | 6,419 |
| Other Income | 14,852 | 305 | 1,788 | 503 | 1,058 |
| Pre-tax Income | 9,649 | -13,404 | -24,391 | -199,285 | -23,708 |
| Income Tax | -53 | -160 | 100 | -22 | 232 |
| Net Income Continuous | 9,702 | -13,244 | -24,491 | -199,263 | -23,940 |
| Net Income | $9,702 | $-13,244 | $-24,491 | $-199,263 | $-23,940 |
| EPS Basic Total Ops | 0.28 | -0.39 | -0.72 | -5.88 | -0.71 |
| EPS Basic Continuous Ops | 0.28 | -0.39 | -0.72 | -5.88 | -0.71 |
| EPS Diluted Total Ops | 0.28 | -0.39 | -0.72 | -5.88 | -0.71 |
| EPS Diluted Continuous Ops | 0.28 | -0.39 | -0.72 | -5.88 | -0.71 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.39 | -0.72 | -0.49 | -0.70 |
| EBITDA(a) | $8,329 | $6,601 | $-5,249 | $-175,946 | $-9,759 |